Andy Roemhild

458 total citations
11 papers, 197 citations indexed

About

Andy Roemhild is a scholar working on Immunology, Oncology and Epidemiology. According to data from OpenAlex, Andy Roemhild has authored 11 papers receiving a total of 197 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 6 papers in Oncology and 6 papers in Epidemiology. Recurrent topics in Andy Roemhild's work include Immune Cell Function and Interaction (7 papers), Cytomegalovirus and herpesvirus research (6 papers) and T-cell and B-cell Immunology (5 papers). Andy Roemhild is often cited by papers focused on Immune Cell Function and Interaction (7 papers), Cytomegalovirus and herpesvirus research (6 papers) and T-cell and B-cell Immunology (5 papers). Andy Roemhild collaborates with scholars based in Germany, United States and United Kingdom. Andy Roemhild's co-authors include Petra Reinke, Hans‐Dieter Volk, Daniel R. Kaiser, Gordon Brestrich, Markus Hammer, Nina Babel, Leila Amini, Sybille Landwehr-Kenzel, Jaspal Kaeda and Enrico Fritsche and has published in prestigious journals such as Kidney International, European Journal of Immunology and Transplantation.

In The Last Decade

Andy Roemhild

11 papers receiving 195 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andy Roemhild Germany 10 113 71 61 22 20 11 197
Hannes Vietzen Austria 10 196 1.7× 74 1.0× 86 1.4× 40 1.8× 31 1.6× 27 340
Lauren E. Higdon United States 9 249 2.2× 46 0.6× 107 1.8× 31 1.4× 48 2.4× 19 354
Bérangère Neveu France 5 283 2.5× 70 1.0× 123 2.0× 9 0.4× 44 2.2× 5 339
Zeying Du United States 7 255 2.3× 19 0.3× 42 0.7× 35 1.6× 12 0.6× 10 325
Sara Bolivar-Wagers United States 8 170 1.5× 114 1.6× 21 0.3× 7 0.3× 45 2.3× 10 250
Nina Salabert France 8 166 1.5× 16 0.2× 32 0.5× 17 0.8× 51 2.5× 11 247
Yvonne M. Zoet Netherlands 10 213 1.9× 84 1.2× 80 1.3× 83 3.8× 40 2.0× 17 326
Dimana Dimitrova United States 8 62 0.5× 13 0.2× 30 0.5× 9 0.4× 19 0.9× 26 135
Juliana Silva United Kingdom 6 74 0.7× 33 0.5× 103 1.7× 14 0.6× 23 1.1× 10 222
Anja M. Jansen-Hoogendijk Netherlands 9 130 1.2× 38 0.5× 52 0.9× 34 1.5× 11 0.6× 14 260

Countries citing papers authored by Andy Roemhild

Since Specialization
Citations

This map shows the geographic impact of Andy Roemhild's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andy Roemhild with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andy Roemhild more than expected).

Fields of papers citing papers by Andy Roemhild

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andy Roemhild. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andy Roemhild. The network helps show where Andy Roemhild may publish in the future.

Co-authorship network of co-authors of Andy Roemhild

This figure shows the co-authorship network connecting the top 25 collaborators of Andy Roemhild. A scholar is included among the top collaborators of Andy Roemhild based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andy Roemhild. Andy Roemhild is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Amini, Leila, Jaspal Kaeda, Enrico Fritsche, et al.. (2023). Clinical adoptive regulatory T Cell therapy: State of the art, challenges, and prospective. Frontiers in Cell and Developmental Biology. 10. 1081644–1081644. 22 indexed citations
2.
Landwehr-Kenzel, Sybille, Mohamed Abou‐El‐Enein, Daniel R. Kaiser, et al.. (2022). Adoptive transfer of ex vivo expanded regulatory T cells improves immune cell engraftment and therapy-refractory chronic GvHD. Molecular Therapy. 30(6). 2298–2314. 21 indexed citations
3.
Kaiser, Daniel R., Natalie Otto, Ghazaleh Zarrinrad, et al.. (2021). Freezing Medium Containing 5% DMSO Enhances the Cell Viability and Recovery Rate After Cryopreservation of Regulatory T Cell Products ex vivo and in vivo. Frontiers in Cell and Developmental Biology. 9. 750286–750286. 19 indexed citations
4.
Ou, Kristy, Andy Roemhild, Daniel R. Kaiser, et al.. (2021). Strong Expansion of Human Regulatory T Cells for Adoptive Cell Therapy Results in Epigenetic Changes Which May Impact Their Survival and Function. Frontiers in Cell and Developmental Biology. 9. 751590–751590. 14 indexed citations
5.
Landwehr-Kenzel, Sybille, Niels Landwehr, Michael Schmueck‐Henneresse, et al.. (2018). Ex vivo expanded natural regulatory T cells from patients with end-stage renal disease or kidney transplantation are useful for autologous cell therapy. Kidney International. 93(6). 1452–1464. 18 indexed citations
6.
Roemhild, Andy & Petra Reinke. (2015). Virus-specific T-cell therapy in solid organ transplantation. Transplant International. 29(5). 515–526. 12 indexed citations
7.
Fischer, Andréas, Gordon Brestrich, Marcin W. Włodarski, et al.. (2012). Cytomegalovirus-Specific Regulatory T Cells and their Role in Repetitive CMV Infections in Solid Organ Transplanted Patients. Transplantation. 94(10S). 111–111. 1 indexed citations
8.
Fischer, Annika, Gordon Brestrich, Marcin W. Włodarski, et al.. (2011). Cytomegalovirus-Specific Regulatory and Effector T Cells Share TCR Clonality—Possible Relation to Repetitive CMV Infections. American Journal of Transplantation. 12(3). 669–681. 40 indexed citations
9.
Guerreiro, Manuel, Il‐Kang Na, Anne Letsch, et al.. (2010). Human peripheral blood and bone marrow Epstein–Barr virus‐specific T‐cell repertoire in latent infection reveals distinct memory T‐cell subsets. European Journal of Immunology. 40(6). 1566–1576. 23 indexed citations
10.
Brestrich, Gordon, Andy Roemhild, Michel Noutsias, et al.. (2009). Generation of HCMV-specific T-cell Lines From Seropositive Solid-organ-transplant Recipients for Adoptive T-cell Therapy. Journal of Immunotherapy. 32(9). 932–940. 17 indexed citations
11.
Hammer, Markus, Gordon Brestrich, Andy Roemhild, et al.. (2007). Generation of EBV-specific T Cells for Adoptive Immunotherapy: A Novel Protocol Using Formalin-fixed Stimulator Cells to Increase Biosafety. Journal of Immunotherapy. 30(8). 817–824. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hannes Vietzen Breakdown of academic impact, for papers by Lauren E. Higdon Breakdown of academic impact, for papers by Bérangère Neveu Breakdown of academic impact, for papers by Zeying Du Breakdown of academic impact, for papers by Sara Bolivar-Wagers Breakdown of academic impact, for papers by Nina Salabert Breakdown of academic impact, for papers by Yvonne M. Zoet Breakdown of academic impact, for papers by Dimana Dimitrova Breakdown of academic impact, for papers by Juliana Silva Breakdown of academic impact, for papers by Anja M. Jansen-Hoogendijk
Rankless by CCL
2026